Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-18

Clinical Trial Update: Women-Focused HIV Prevention in the Western Cape [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 HIV prevention trials for women in the Western Cape have completed, sponsored by NICHD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: HIV, Substance Abuse | Phase 2, Phase 3 | Status: COMPLETED